✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
Home › Product Catalog › Dapiprazole

Dapiprazole

CAS 72822-12-9C19H27N5MW 325.5

Dapiprazole (CAS 72822-12-9) — formula C19H27N5, molecular weight 325.5.

Product Overview

CAS Number72822-12-9
Molecular FormulaC19H27N5
Molecular Weight325.5
LogP2.3

Technical Profile

What this product is

Dapiprazole is a chemical compound with CAS registry number 72822-12-9 and molecular formula C19H27N5 (molecular weight 325.5).

Identification

CAS number: 72822-12-9

Its molecular formula C19H27N5 comprises 19 C, 27 H, 5 N atoms.

Also known as: Dapiprazole · 达哌唑

Frequently Asked Questions

What is the CAS number of Dapiprazole?

The CAS registry number of Dapiprazole is 72822-12-9.

What is the molecular formula and molecular weight of Dapiprazole?

Molecular formula C19H27N5, molecular weight 325.5.

What other names is Dapiprazole known by?

It is also registered under: Dapiprazole, 达哌唑.

PubChem Public Data

Independent reference data for Dapiprazole (CAS 72822-12-9), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number72822-12-9
PubChem CID3033538
Molecular formulaC19H27N5
IUPAC name3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine
UNII (FDA)5RNZ8GJO7K

Computed descriptors

Molecular Weight325.5
XLogP32.4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass325.22664588
Monoisotopic Mass325.22664588
Topological Polar Surface Area37.2
Heavy Atom Count24

Physicochemical values on record

Solubility7.51e-01 g/L
LogP2.3

Documented uses on record

    Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

    Synonyms and trade names

    Dapiprazole; 72822-12-9; Dapiprazol; dapiprazolum; 5RNZ8GJO7K; 5,6,7,8-Tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine; CHEBI:51066; DTXSID90223140; 1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine; 1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-; dapiprazolo; 1-(2-methylphenyl)-4-(2-(5H,6H,7H,8H-(1,2,4)triazolo(4,3-a)pyridin-3-yl)ethyl)piperazine; RefChem:57621; DTXCID90145631; S01EX02; Dapiprazole [INN]

    GHS hazard classification

    Reported hazard statementsH315 (100%), H319 (100%)

    H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

    H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

    What the public record says

    Dapiprazole · CAS 72822-12-9 · C19H27N5. UNII 5RNZ8GJO7K. Solubility: 7.51e-01 g/L; LogP: 2.3.

    Physical description and handling notes

    Source: PubChem / Wikidata; the batch COA governs where values differ.

Request a Quote

✉ info@591daili.com☎ +86-18553102138📞 WhatsAppEmail InquiryWhatsApp Inquiry

Supplier: Jinan Shenghe Chemical Co., Ltd.

中文页面: 达哌唑

鲁ICP备19031700号-2